New Zealand markets closed

ALGN Oct 2024 190.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.06000.0000 (0.00%)
As of 09:30AM EDT. Market open.
Full screen
Loading interactive chart…
  • Business Wire

    Invisalign® Palatal Expander System by Align Technology Now Available in Singapore for Skeletal and Dental Expansion in Growing Patients

    SINGAPORE, October 15, 2024--Align Technology, Inc. ("Align") (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align's Invisalign Palatal Expander System has been listed on the Singapore Medical Device Register as a class B medical device. It is now commercially available in Singapore

  • Business Wire

    Align Technology to Announce Third Quarter 2024 Results on October 23, 2024

    TEMPE, Ariz., October 02, 2024--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2024 financial results on Wednesday, October 23, 2024, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and

  • Business Wire

    Court Grants Preliminary Approval of Settlement to Resolve All Outstanding Shareholder Derivative Litigation Involving Align

    TEMPE, Ariz., October 01, 2024--Align Technology, Inc. ("Align") (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the U.S. District Court for the Northern District of California has granted preliminary approval of a settlement to resolve shareholder derivative litigation that has been